Unternehmen ESSA Pharma Inc. Toronto S.E.
Aktien
A2JKQ4
CA29668H7085
EPI
Biotechnologie
Kurzporträt
Mitarbeiterzahl: 50
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
David Parkinson
CEO | Chief Executive Officer | 73 | 24.06.15 |
David Wood
DFI | Director of Finance/CFO | 66 | 01.10.13 |
Peter Virsik
COO | Chief Operating Officer | - | 01.08.16 |
Chief Tech/Sci/R&D Officer | 63 | 15.07.19 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Franklin Berger
BRD | Director/Board Member | 74 | 05.03.15 |
Sanford Zweifach
BRD | Director/Board Member | 68 | 31.07.19 |
Richard Glickman
CHM | Chairman | 65 | 01.10.10 |
Director/Board Member | 55 | 31.07.19 | |
Scott Requadt
BRD | Director/Board Member | 56 | 14.01.16 |
David Parkinson
CEO | Chief Executive Officer | 73 | 24.06.15 |
Philip Kantoff
BRD | Director/Board Member | 69 | 13.09.22 |
Ann Thorell
BRD | Director/Board Member | 56 | 31.07.19 |
Gary Sollis
BRD | Director/Board Member | 69 | 26.04.12 |
Lauren Merendino
BRD | Director/Board Member | 49 | 06.06.23 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 44 238 147 | 43 234 049 ( 97,73 %) | 0 | 97,73 % |
Unternehmenskontakt
Sektor
% 1. Jan. | Kap. | |
---|---|---|
+4.09% | 43.84 Mrd. | |
+46.85% | 41.25 Mrd. | |
+9.45% | 41.68 Mrd. | |
-10.92% | 27.04 Mrd. | |
+9.32% | 25.53 Mrd. | |
-24.87% | 18.18 Mrd. | |
+29.70% | 12.29 Mrd. | |
+1.28% | 12.29 Mrd. | |
+7.78% | 11.15 Mrd. |